JPWO2021202694A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021202694A5 JPWO2021202694A5 JP2022559873A JP2022559873A JPWO2021202694A5 JP WO2021202694 A5 JPWO2021202694 A5 JP WO2021202694A5 JP 2022559873 A JP2022559873 A JP 2022559873A JP 2022559873 A JP2022559873 A JP 2022559873A JP WO2021202694 A5 JPWO2021202694 A5 JP WO2021202694A5
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- acceptable salt
- cationic lipid
- optionally substituted
- ceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025244099A JP2026048786A (ja) | 2020-04-01 | 2025-12-10 | フェノール酸脂質系カチオン性脂質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003698P | 2020-04-01 | 2020-04-01 | |
| US63/003,698 | 2020-04-01 | ||
| PCT/US2021/025128 WO2021202694A1 (en) | 2020-04-01 | 2021-03-31 | Phenolic acid lipid based cationic lipids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025244099A Division JP2026048786A (ja) | 2020-04-01 | 2025-12-10 | フェノール酸脂質系カチオン性脂質 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023520047A JP2023520047A (ja) | 2023-05-15 |
| JP2023520047A5 JP2023520047A5 (https=) | 2024-04-11 |
| JPWO2021202694A5 true JPWO2021202694A5 (https=) | 2024-04-11 |
| JP7791103B2 JP7791103B2 (ja) | 2025-12-23 |
Family
ID=75625666
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559873A Active JP7791103B2 (ja) | 2020-04-01 | 2021-03-31 | フェノール酸脂質系カチオン性脂質 |
| JP2025244099A Pending JP2026048786A (ja) | 2020-04-01 | 2025-12-10 | フェノール酸脂質系カチオン性脂質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025244099A Pending JP2026048786A (ja) | 2020-04-01 | 2025-12-10 | フェノール酸脂質系カチオン性脂質 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4126813A1 (https=) |
| JP (2) | JP7791103B2 (https=) |
| CN (2) | CN121318756A (https=) |
| WO (1) | WO2021202694A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4313115A1 (en) | 2021-03-25 | 2024-02-07 | Translate Bio, Inc. | Optimized nucleotide sequences encoding the extracellular domain of human ace2 protein or a portion thereof |
| US20250073351A1 (en) * | 2021-04-19 | 2025-03-06 | Translate Bio, Inc. | Improved compositions for delivery of mrna |
| MX2024002726A (es) | 2021-09-03 | 2024-03-20 | CureVac SE | Nuevas nanoparticulas lipidicas para la administracion de acidos nucleicos. |
| WO2023073228A1 (en) | 2021-10-29 | 2023-05-04 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| US20250099614A1 (en) | 2022-01-28 | 2025-03-27 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| WO2023227608A1 (en) | 2022-05-25 | 2023-11-30 | Glaxosmithkline Biologicals Sa | Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide |
| WO2024089638A1 (en) | 2022-10-28 | 2024-05-02 | Glaxosmithkline Biologicals Sa | Nucleic acid based vaccine |
| WO2024133515A1 (en) | 2022-12-20 | 2024-06-27 | Sanofi | Rhinovirus mrna vaccine |
| KR20250153298A (ko) | 2023-03-08 | 2025-10-24 | 큐어백 에스이 | 핵산 전달을 위한 신규의 지질 나노입자 제형 |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
| WO2025189064A1 (en) | 2024-03-08 | 2025-09-12 | Genzyme Corporation | Lipid nanoparticles |
| WO2026003373A1 (en) | 2024-06-28 | 2026-01-02 | Sanofi | Phenolic acid lipid based cationic lipids |
| WO2026008743A1 (en) | 2024-07-02 | 2026-01-08 | Sanofi Pasteur Inc. | Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| US6472397B1 (en) * | 1998-04-09 | 2002-10-29 | Meiji Seika Kaisha, Ltd. | Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof |
| JP6557722B2 (ja) | 2014-05-30 | 2019-08-07 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | 核酸の送達のための生分解性脂質 |
| HRP20220652T1 (hr) * | 2015-12-10 | 2022-06-24 | Modernatx, Inc. | Pripravci i postupci unosa terapijskih sredstava |
| MA45032A (fr) | 2016-05-18 | 2019-03-27 | Fundacion Para La Investig Medica Aplicada | Polynucléotides codant pour la porphobilinogène désaminase destinés au traitement de la porphyrie intermittente aiguë |
| WO2018089801A1 (en) | 2016-11-10 | 2018-05-17 | Translate Bio, Inc. | Improved process of preparing mrna-loaded lipid nanoparticles |
| SMT202300097T1 (it) | 2017-03-15 | 2023-05-12 | Modernatx Inc | Composto e composizioni per il rilascio intracellulare di agenti terapeutici |
| CN112437767B (zh) * | 2018-05-24 | 2023-10-27 | 川斯勒佰尔公司 | 硫酯阳离子脂质 |
| EP3849617A1 (en) * | 2018-09-14 | 2021-07-21 | Translate Bio, Inc. | Composition and methods for treatment of methylmalonic acidemia |
| CN110526885A (zh) * | 2019-08-20 | 2019-12-03 | 上海英诺富成生物科技有限公司 | 麦考酚酸的前体药物及其制备方法 |
-
2021
- 2021-03-31 WO PCT/US2021/025128 patent/WO2021202694A1/en not_active Ceased
- 2021-03-31 CN CN202511243318.7A patent/CN121318756A/zh active Pending
- 2021-03-31 EP EP21720636.6A patent/EP4126813A1/en active Pending
- 2021-03-31 CN CN202180039080.XA patent/CN115667207B/zh active Active
- 2021-03-31 JP JP2022559873A patent/JP7791103B2/ja active Active
-
2025
- 2025-12-10 JP JP2025244099A patent/JP2026048786A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021202694A5 (https=) | ||
| JP7326622B2 (ja) | Ｅｒｋ阻害剤としてのスピロ系化合物およびその使用 | |
| AU703340B2 (en) | Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis | |
| ES2274973T3 (es) | Inhibidores de la agregacion de placas amiloides y agentes de obtencion de imagenes diagnosticas. | |
| JP2004514663A5 (https=) | ||
| JPWO2021244831A5 (https=) | ||
| JP2004517843A5 (https=) | ||
| US6387891B2 (en) | Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury | |
| JP2001247459A5 (https=) | ||
| JP2010500376A5 (https=) | ||
| JP2004518704A5 (https=) | ||
| JPWO2022177917A5 (https=) | ||
| SK68997A3 (en) | Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography | |
| JPWO2019195124A5 (https=) | ||
| RU2000102359A (ru) | Фармацевтическая композиция, обладающая улучшенным противораковым действием и/или сниженными побочными эффектами, содержащая противораковый агент и производное гидроксамовой кислоты | |
| RU2003133924A (ru) | Дейтерированные 3-пиперидиноэтилфенилкетоны, а также лекарственные средства, содержащие эти соединения | |
| US6303101B1 (en) | Bismuth compounds | |
| JPWO2020252589A5 (https=) | ||
| JPH0920659A5 (https=) | ||
| JP2021530554A5 (https=) | ||
| EP0717639A1 (en) | Polyamino paramagnetic chelates which contain both phosphonate and non-phosphonate moieties for mri | |
| JPWO2022066916A5 (https=) | ||
| CN110845408A (zh) | 同位素富集的乐伐替尼 | |
| US5616312A (en) | Thiol ligands and complexes for X-ray imaging | |
| JPH10505856A (ja) | ヨウ素化ｘ線コントラスト媒体 |